S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Consumers are increasingly pushing back against price increases — and winning
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
BREAKING: Tiny biotech successfully treats blindness (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Consumers are increasingly pushing back against price increases — and winning
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
BREAKING: Tiny biotech successfully treats blindness (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Consumers are increasingly pushing back against price increases — and winning
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
BREAKING: Tiny biotech successfully treats blindness (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
BREAKING: Tiny biotech successfully treats blindness (Ad)
Consumers are increasingly pushing back against price increases — and winning
Corruption scandals cast a shadow over Portugal’s early general election and may favor populists
BREAKING: Tiny biotech successfully treats blindness (Ad)
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
BREAKING: Tiny biotech successfully treats blindness (Ad)
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes

Lumos Pharma (LUMO) Institutional Ownership

$3.00
-0.02 (-0.66%)
(As of 02/23/2024 ET)

Institutional Ownership Changes (13F Filings) for Lumos Pharma (NASDAQ:LUMO)

Current
Institutional Ownership
Percentage
35.23%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$465,160.69
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$641,293.64
Get LUMO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lumos Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

LUMO Institutional Buying and Selling by Quarter


Lumos Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Vanguard Group Inc.244,082$0.78M0.0%+3.7%3.086%
2/15/2024Blackstone Inc.326,552$1.04M0.0%-30.2%4.128%
2/6/2024Private Advisor Group LLC16,013$51K0.0%-20.0%0.202%
11/7/2023Greenwich Wealth Management LLC76,341$0.25M0.0%+55.8%0.961%
11/3/2023Private Advisor Group LLC20,013$66K0.0%+42.8%0.252%
10/27/2023Marquette Asset Management LLC25,760$85K0.0%-17.1%0.324%
10/27/2023Acuitas Investments LLC125,242$0.41M0.2%-18.6%1.577%
8/11/2023BlackRock Inc.46,780$0.15M0.0%-18.9%0.573%
8/11/2023Geode Capital Management LLC54,279$0.18M0.0%+58.5%0.664%
8/10/2023Private Advisor Group LLC14,013$46K0.0%-30.0%0.172%
7/31/2023Greenwich Wealth Management LLC49,002$0.16M0.0%+63.2%0.600%
5/12/2023Renaissance Technologies LLC229,914$0.76M0.0%-1.4%2.814%
5/10/2023Private Advisor Group LLC20,013$66K0.0%N/A0.245%
5/1/2023Marquette Asset Management LLC31,088$0.10M0.0%+47.9%0.379%
4/24/2023Greenwich Wealth Management LLC30,028$99K0.0%N/A0.366%
2/15/2023Virtu Financial LLC10,556$38K0.0%N/A0.126%
2/15/2023Shay Capital LLC50,000$0.18M0.1%N/A0.595%
2/15/2023Millennium Management LLC20,037$72K0.0%N/A0.239%
2/15/2023Jefferies Financial Group Inc.120,651$0.44M0.0%N/A1.436%
2/14/2023Price T Rowe Associates Inc. MD100,000$0.36M0.0%-11.2%1.190%
2/13/2023Wells Fargo & Company MN318,220$1.15M0.0%-2.5%3.788%
2/13/2023Renaissance Technologies LLC233,114$0.84M0.0%-6.9%2.775%
2/10/2023K2 Principal Fund L.P.15,836$57K0.0%-71.7%0.189%
2/7/2023Envestnet Asset Management Inc.10,509$38K0.0%N/A0.125%
1/18/2023Private Advisor Group LLC20,013$72K0.0%+17.6%0.238%
1/12/2023Marquette Asset Management LLC21,020$76K0.0%+57.9%0.250%
11/15/2022Price T Rowe Associates Inc. MD112,576$1M0.0%-12.0%1.341%
11/14/2022Renaissance Technologies LLC250,513$2.22M0.0%-7.3%2.984%
10/14/2022Private Advisor Group LLC17,013$0.15M0.0%-37.0%0.203%
8/16/2022Price T Rowe Associates Inc. MD127,994$0.99M0.0%-19.8%1.527%
8/15/2022Opaleye Management Inc.21,520$0.17M0.1%N/A0.257%
8/13/2022Renaissance Technologies LLC270,112$2.08M0.0%-0.6%3.228%
7/26/2022Key Financial Inc10,916$84K0.0%N/A0.130%
7/22/2022Urban Wealth Management LLC3,490$27K0.1%N/A0.042%
5/13/2022Renaissance Technologies LLC271,712$2.55M0.0%-1.9%3.251%
5/12/2022BlackRock Inc.59,460$0.56M0.0%-3.3%0.711%
5/12/2022Private Advisor Group LLC28,013$0.26M0.0%N/A0.335%
2/15/2022Lion Point Capital LP51,205$0.35M0.1%-87.4%0.613%
2/4/2022Envestnet Asset Management Inc.10,368$72K0.0%N/A0.124%
2/2/2022PVG Asset Management Corp10,175$71K0.3%N/A0.122%
1/14/2022Investors Financial Group LLC30,600$0.21M0.1%-11.6%0.366%
11/15/2021Minerva Advisors LLC34,015$0.32M0.2%N/A0.407%
11/12/2021Renaissance Technologies LLC286,412$2.72M0.0%-6.3%3.427%
11/12/2021Connor Clark & Lunn Investment Management Ltd.33,427$0.32M0.0%+4.7%0.400%
10/21/2021Investors Financial Group LLC34,600$0.33M0.2%+16.9%0.414%
10/12/2021Marquette Asset Management LLC13,234$0.13M0.0%+48.4%0.158%
8/17/2021Price T Rowe Associates Inc. MD159,595$1.59M0.0%N/A1.910%
8/16/2021Opaleye Management Inc.382,000$3.82M0.6%+1.4%4.571%
8/16/2021State Street Corp11,237$0.11M0.0%N/A0.134%
8/13/2021Renaissance Technologies LLC305,757$3.06M0.0%-8.0%3.659%
8/12/2021Dimensional Fund Advisors LP39,405$0.39M0.0%-5.0%0.472%
8/12/2021Connor Clark & Lunn Investment Management Ltd.31,938$0.32M0.0%-4.1%0.382%
7/19/2021Marquette Asset Management LLC8,919$89K0.0%N/A0.107%
5/18/2021Opaleye Management Inc.376,900$4.41M0.6%+34.0%4.516%
5/17/2021Deerfield Management Company L.P. Series C373,117$4.37M0.1%-60.1%4.471%
5/14/2021Dimensional Fund Advisors LP41,459$0.49M0.0%-4.8%0.497%
5/13/2021Renaissance Technologies LLC332,419$3.89M0.0%+7.6%3.983%
5/12/2021Northern Trust Corp2,960$35K0.0%-75.5%0.035%
5/11/2021Acadian Asset Management LLC5,879$69K0.0%+65.0%0.070%
5/7/2021BlackRock Inc.71,078$0.83M0.0%+2.9%0.853%
4/14/2021Investors Financial Group LLC29,200$0.34M0.2%+60.4%0.350%
2/22/2021West Financial Advisors LLC784$28K0.0%N/A0.009%
2/18/2021Verition Fund Management LLC9,835$0.35M0.0%N/A0.119%
2/16/2021One68 Global Capital LLC5,855$0.21M0.4%N/A0.071%
2/16/2021ExodusPoint Capital Management LP37,203$1.33M0.0%N/A0.448%
2/12/2021Opaleye Management Inc.281,287$10.05M1.3%+16.8%3.390%
2/11/2021Northern Trust Corp12,081$0.43M0.0%+292.0%0.146%
2/10/2021Renaissance Technologies LLC308,812$11.03M0.0%+0.9%3.722%
2/9/2021Wells Fargo & Company MN117,660$4.20M0.0%+1.1%1.418%
2/9/2021Bank of New York Mellon Corp17,493$0.63M0.0%N/A0.211%
1/21/2021Foster Group Inc.7,283$0.22M0.0%N/A0.088%
1/19/2021Investors Financial Group LLC18,200$0.65M0.4%-16.4%0.219%
11/12/2020Connor Clark & Lunn Investment Management Ltd.31,978$0.44M0.0%-12.5%0.386%
11/10/2020Texas Yale Capital Corp.16,000$0.22M0.0%+6.7%0.193%
11/9/2020Acadian Asset Management LLC5,161$71K0.0%-85.7%0.062%
11/5/2020Wells Fargo & Company MN116,392$1.61M0.0%+3.7%1.403%
10/14/2020Investors Financial Group LLC21,766$0.30M0.2%-81.1%0.262%
9/15/2020Two Sigma Advisers LP13,298$0.22M0.0%-5.0%0.160%
8/14/2020Logos Global Management LP50,000$0.83M0.2%N/A0.606%
8/14/2020Jefferies Group LLC120,651$1.99M0.0%+13.0%1.462%
(Data available from 1/1/2016 forward)













LUMO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LUMO shares?

During the previous two years, 20 institutional investors and hedge funds held shares of Lumos Pharma. The most heavily invested institutionals were Wells Fargo & Company MN ($1.15M), Blackstone Inc. ($1.04M), Vanguard Group Inc. ($0.78M), Renaissance Technologies LLC ($0.76M), Jefferies Financial Group Inc. ($0.44M), Acuitas Investments LLC ($0.41M), and Price T Rowe Associates Inc. MD ($0.36M).Learn more on LUMO's institutional investors.

What percentage of Lumos Pharma stock is owned by institutional investors?

35.23% of Lumos Pharma stock is owned by institutional investors. Learn more on LUMO's institutional investor holdings.

Which institutional investors have been buying Lumos Pharma stock?

Of the 13 institutional investors that purchased Lumos Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jefferies Financial Group Inc. ($0.12M), Greenwich Wealth Management LLC ($76.34K), Private Advisor Group LLC ($57.03K), Shay Capital LLC ($50K), Opaleye Management Inc. ($21.52K), Millennium Management LLC ($20.04K), and Geode Capital Management LLC ($20.02K).

How much institutional buying is happening at Lumos Pharma?

Institutional investors have bought a total of 427,487 shares in the last 24 months. This purchase volume represents approximately $1.81M in transactions.

Which Lumos Pharma major shareholders have been selling company stock?

Of the 9 institutional investors that sold Lumos Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Blackstone Inc. ($0.14M), Price T Rowe Associates Inc. MD ($59.60K), Renaissance Technologies LLC ($47.20K), K2 Principal Fund L.P. ($40.03K), Acuitas Investments LLC ($28.63K), Private Advisor Group LLC ($20K), and BlackRock Inc. ($12.91K).

How much institutional selling is happening at Lumos Pharma?

Institutional investors have sold a total of 363,378 shares in the last 24 months. This volume of shares sold represents approximately $1.65M in transactions.


This page (NASDAQ:LUMO) was last updated on 2/25/2024 by MarketBeat.com Staff